Literature DB >> 18041028

Novel anti-dengue monoclonal antibody recognizing conformational structure of the prM-E heterodimeric complex of dengue virus.

Chunya Puttikhunt1, Poonsook Keelapang, Nuanpan Khemnu, Nopporn Sittisombut, Watchara Kasinrerk, Prida Malasit.   

Abstract

An interaction between the premembrane (prM) and envelope (E) glycoproteins as prM-E heterodimer is required for proper folding and transport of E during the formation and release of new flaviviral progeny. More evidence, however, is needed to confirm this interaction of prM and E during dengue virus replication. In this study, 2E11, a mouse monoclonal antibody (Mab) that specifically recognizes dengue prM-E heterodimeric complex in either intracellular or secreted dengue virions, was generated and characterized. In immunofluorescence and immuno-pull down assays, the Mab 2E11 recognized an epitope present in 293T transfectants that co-expressed prM and the full-length form of E in cis and in trans, but it failed to react with prM or E protein expressed individually. The reactivity of Mab 2E11 was diminished in transfected cells that co-express prM together with a truncated form of E lacking the 84-residue stretch at the C-terminal transmembrane region, presumably essential for prM and E interaction. The Mab 2E11 described in this study is a novel Mab with a unique capability in detecting the conformational structure of prM-E heterodimeric complex of dengue virus. It will be a new biological tool for identification and characterization of dengue prM-E heterodimer as well as virus maturation and export. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18041028     DOI: 10.1002/jmv.21047

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Electrostatic engineering of the interface between heavy and light chains promotes antibody Fab fragment production.

Authors:  Yuki Ohmuro-Matsuyama; Keita Mori; Hirotsugu Hamada; Hiroshi Ueda; Hideki Yamaji
Journal:  Cytotechnology       Date:  2016-02-08       Impact factor: 2.058

2.  Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly.

Authors:  Melissanne de Wispelaere; Priscilla L Yang
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Modifications of a signal sequence for antibody secretion from insect cells.

Authors:  Yuki Ohmuro-Matsuyama; Hideki Yamaji
Journal:  Cytotechnology       Date:  2017-06-05       Impact factor: 2.058

4.  The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

Authors:  Martina Beltramello; Katherine L Williams; Cameron P Simmons; Annalisa Macagno; Luca Simonelli; Nguyen Than Ha Quyen; Soila Sukupolvi-Petty; Erika Navarro-Sanchez; Paul R Young; Aravinda M de Silva; Félix A Rey; Luca Varani; Stephen S Whitehead; Michael S Diamond; Eva Harris; Antonio Lanzavecchia; Federica Sallusto
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

5.  Cross-reacting antibodies enhance dengue virus infection in humans.

Authors:  Wanwisa Dejnirattisai; Amonrat Jumnainsong; Naruthai Onsirisakul; Patricia Fitton; Sirijitt Vasanawathana; Wannee Limpitikul; Chunya Puttikhunt; Carolyn Edwards; Thaneeya Duangchinda; Sunpetchuda Supasa; Kriangkrai Chawansuntati; Prida Malasit; Juthathip Mongkolsapaya; Gavin Screaton
Journal:  Science       Date:  2010-05-07       Impact factor: 47.728

6.  A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein.

Authors:  Annie Hoi Yi Chan; Hwee Cheng Tan; Angelia Yee Chow; Angeline Pei Chiew Lim; Shee Mei Lok; Nicole J Moreland; Subhash G Vasudevan; Paul A MacAry; Eng Eong Ooi; Brendon J Hanson
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

7.  Dengue patients exhibit higher levels of PrM and E antibodies than their asymptomatic counterparts.

Authors:  Adeline Syin Lian Yeo; Anusyah Rathakrishnan; Seok Mui Wang; Sasheela Ponnampalavanar; Rishya Manikam; Jameela Sathar; Santha Kumari Natkunam; Shamala Devi Sekaran
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

8.  Decrease in Dengue virus-2 infection and reduction of cytokine/chemokine production by Uncaria guianensis in human hepatocyte cell line Huh-7.

Authors:  Cíntia da Silva Mello; Ligia Maria Marino Valente; Thiago Wolff; Raimundo Sousa Lima-Junior; Luciana Gomes Fialho; Cintia Ferreira Marinho; Elzinandes Leal Azeredo; Luzia Maria Oliveira-Pinto; Rita de Cássia Alves Pereira; Antonio Carlos Siani; Claire Fernandes Kubelka
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-06       Impact factor: 2.743

9.  A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Authors:  Wanwisa Dejnirattisai; Wiyada Wongwiwat; Sunpetchuda Supasa; Xiaokang Zhang; Xinghong Dai; Alexander Rouvinski; Amonrat Jumnainsong; Carolyn Edwards; Nguyen Than Ha Quyen; Thaneeya Duangchinda; Jonathan M Grimes; Wen-Yang Tsai; Chih-Yun Lai; Wei-Kung Wang; Prida Malasit; Jeremy Farrar; Cameron P Simmons; Z Hong Zhou; Felix A Rey; Juthathip Mongkolsapaya; Gavin R Screaton
Journal:  Nat Immunol       Date:  2014-12-15       Impact factor: 25.606

Review 10.  Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

Authors:  Lucas Wilken; Guus F Rimmelzwaan
Journal:  Pathogens       Date:  2020-06-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.